EUVIMED · CrossrefZeitschrift
Oncology in Clinical Practice
ISSN 2450-1654 · VM Media Group sp. z o.o
Neueste Artikel
Locally advanced thoracic NUT carcinoma — a case report and literature review
Development and validation of a mobile application assisting oncologists with prescribing appropriate thromboprophylaxis for ambulatory cancer patients with high risk of thromboembolism — a pilot study
Oral mucositis pain management — an overview of current guidelines and clinical approaches
Nanoparticles in targeted breast cancer therapy — advances and challenges
Prognostic impact of MYC and BCL2 co-expression in diffuse large B-cell lymphoma treated with R-CHOP: a systematic review and meta-analysis
Oral microbiome and treatment response in head and neck cancer: implications for clinical practice
Durable complete response in advanced pancreatic ductal adenocarcinoma following prolonged gemcitabine monotherapy and stereotactic body radiotherapy
Letter to the Editor: Early molecular switching with camizestrant in clinical practice
Ivosidenib in the treatment of patients with IDH1 mutated cholangiocarcinoma
Evaluation of the Timed Up and Go test for screening vulnerability and frailty in older cancer patients
Leptomeningeal metastasis in primary uterine cervical cancer: a rare case and review of the literature
Spermatic cord tumors — review of the literature
HER2-low — the new subtype of breast cancer?
Recommendations for testing of predictive marker HER2 in patients with invasive breast cancer. Recommendations in accordance with American Society of Clinical Oncology (ASCO) guidelines from 30th May 2018
Complications of immunotherapy in the course of long-term response in a patient with non-small cell lung cancer
Late side effects in the thyroid gland in association with transforming growth factor β1 (TGF-β1) levels in patients with head and neck cancers treated with radiation therapy
Combination of chemotherapy and endocrine treatment in breast cancer — is it still a taboo?
Commentary on Diagnostics and treatment of BRCA-associated cancers with olaparib — expert position statement
Pocket hematoma that turned out to be cancer
Pulmonary large cell neuroendocrine carcinoma — diagnostic and therapeutic clinical dilemmas
Advancements in non-small cell lung cancer treatment: from early to advanced stages
Prognostic significance of pretreatment clinical and laboratory features in patients with ovarian cancer receiving neoadjuvant chemotherapy
Systemic treatment of EGFR-mutated non-small cell lung cancer
Metastatic prostate adenocarcinoma presenting with ptosis due to sphenoid sinus metastasis — a rare case report
Diagnosis and treatment of pleural mesothelioma. State of the art 2024
An axis involving TPX2/hsa-let-7b-5p/TMPO-AS1 promotes lung adenocarcinoma in smokers
Cervical cancer in Poland — epidemiology, prevention, and treatment pathways
Lymph node metastases, sentinel lymph node biopsy, and lymphadenectomy in soft tissue sarcoma — when and why?
Mobile applications in treatment of cancer pain — a systematic review
Gustave Roussy immune score is an independent prognostic factor for treatment response and survival in advanced non-small cell lung cancer treated with nivolumab at second-line therapy
EUVIMED